Assessment of the Accuracy of Using ICD-9 Diagnosis Codes to Identify Pneumonia Etiology in Patients Hospitalized With Pneumonia

Thomas L Higgins, Abhishek Deshpande, Marya D Zilberberg, Peter K Lindenauer, Peter B Imrey, Pei-Chun Yu, Sarah D Haessler, Sandra S Richter, Michael B Rothberg, Thomas L Higgins, Abhishek Deshpande, Marya D Zilberberg, Peter K Lindenauer, Peter B Imrey, Pei-Chun Yu, Sarah D Haessler, Sandra S Richter, Michael B Rothberg

Abstract

Importance: Administrative databases may offer efficient clinical data collection for studying epidemiology, outcomes, and temporal trends in health care delivery. However, such data have seldom been validated against microbiological laboratory results.

Objective: To assess the validity of International Classification of Diseases, Ninth Revision (ICD-9) organism-specific administrative codes for pneumonia using microbiological data (test results for blood or respiratory culture, urinary antigen, or polymerase chain reaction) as the criterion standard.

Design, setting, and participants: Cross-sectional diagnostic accuracy study conducted between February 2017 and June 2019 using data from 178 US hospitals in the Premier Healthcare Database. Patients were aged 18 years or older admitted with pneumonia and discharged between July 1, 2010, and June 30, 2015. Data were analyzed from February 14, 2017, to June 27, 2019.

Exposures: Organism-specific pneumonia identified from ICD-9 codes.

Main outcomes and measures: Sensitivity, specificity, positive predictive value, and negative predictive value of ICD-9 codes using microbiological data as the criterion standard.

Results: Of 161 529 patients meeting inclusion criteria (mean [SD] age, 69.5 [16.2] years; 51.2% women), 35 759 (22.1%) had an identified pathogen. ICD-9-coded organisms and laboratory findings differed notably: for example, ICD-9 codes identified only 14.2% and 17.3% of patients with laboratory-detected methicillin-sensitive Staphylococcus aureus and Escherichia coli, respectively. Although specificities and negative predictive values exceeded 95% for all codes, sensitivities ranged downward from 95.9% (95% CI, 95.3%-96.5%) for influenza virus to 14.0% (95% CI, 8.8%-20.8%) for parainfluenza virus, and positive predictive values ranged downward from 91.1% (95% CI, 89.5%-92.6%) for Staphylococcus aureus to 57.1% (95% CI, 39.4%-73.7%) for parainfluenza virus.

Conclusions and relevance: In this study, ICD-9 codes did not reliably capture pneumonia etiology identified by laboratory testing; because of the high specificities of ICD-9 codes, however, administrative data may be useful in identifying risk factors for resistant organisms. The low sensitivities of the diagnosis codes may limit the validity of organism-specific pneumonia prevalence estimates derived from administrative data.

Conflict of interest statement

Conflict of Interest Disclosures: Dr Deshpande reported receiving grants from the Agency for Healthcare Research and Quality (AHRQ) during the conduct of the study; grants and nonfinancial support from Clorox Company and other support from Ferring Pharmaceuticals outside the submitted work. Dr Zilberberg reported receiving personal fees from Cleveland Clinic during the conduct of the study; grants from Spero, grants from Merck, personal fees from Nabriva, personal fees from Melinta, grants from Lungpacer, grants from Astellas, other support from JNJ, grants from Tetraphase, and grants from The Medicines Company outside the submitted work. Dr Imrey reported receiving grants from the AHRQ during the conduct of the study. Dr Haessler reported receiving grants from the AHRQ during the conduct of the study. Dr Richter reported receiving grants from the AHRQ during the conduct of the study; grants and other support from bioMerieux, grants from BD Diagnostics, grants from Hologic, grants from Diasorin, grants from Lifescale Affinity, grants from Roche, and grants from ARLG outside the submitted work. Dr Rothberg reported receiving grants from the AHRQ during the conduct of the study. No other disclosures were reported.

Figures

Figure.. Participant Selection Flow Diagram
Figure.. Participant Selection Flow Diagram
Abbreviations: CT, computed tomography; LOS, length of stay (in days); PDX, principal diagnosis; POA, present on admission; SDX, secondary diagnosis. aPatients with viral pneumonia as principal diagnosis but without initial antibiotic treatments were included. bOn a 1-patient 1-admission basis, with a single eligible admission randomly selected from each patient's eligible admissions (178 hospitals).

References

    1. CDC/NHSN Surveillance of Healthcare-Associated Infections Accessed August 1, 2019.
    1. CDC’s Prevention Epicenters Program Accessed August 1, 2019.
    1. Lindenauer PK, Lagu T, Shieh MS, Pekow PS, Rothberg MB. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA. 2012;307(13):1405-1413. doi:10.1001/jama.2012.384
    1. Aronsky D, Haug PJ, Lagor C, Dean NC. Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual. 2005;20(6):319-328. doi:10.1177/1062860605280358
    1. Rothberg MB, Pekow PS, Priya A, et al. . Using highly detailed administrative data to predict pneumonia mortality. PLoS One. 2014;9(1):e87382. doi:10.1371/journal.pone.0087382
    1. The US Census Bureau Urban and rural. Accessed June 24, 2020.
    1. Gupta NM, Lindenauer PK, Yu PC, et al. . Association between alcohol use disorders and outcomes of patients hospitalized with community-acquired pneumonia. JAMA Netw Open. 2019;2(6):e195172. doi:10.1001/jamanetworkopen.2019.5172
    1. The US Census Bureau Statistical groupings of states and counties. Accessed June 24, 2020.
    1. Guevara RE, Butler JC, Marston BJ, Plouffe JF, File TM Jr, Breiman RF. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol. 1999;149(3):282-289. doi:10.1093/oxfordjournals.aje.a009804
    1. Schweizer ML, Eber MR, Laxminarayan R, et al. . Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol. 2011;32(2):148-154. doi:10.1086/657936
    1. Burnham JP, Kwon JH, Babcock HM, Olsen MA, Kollef MH. ICD-9-CM coding for multidrug resistant infection correlates poorly with microbiologically confirmed multidrug resistant infection. Infect Control Hosp Epidemiol. 2017;38(11):1381-1383. doi:10.1017/ice.2017.192
    1. Ramirez JA, Wiemken TL, Peyrani P, et al. ; University of Louisville Pneumonia Study Group . Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65(11):1806-1812. doi:10.1093/cid/cix647
    1. Smith SB, Ruhnke GW, Weiss CH, Waterer GW, Wunderink RG. Trends in pathogens among patients hospitalized for pneumonia from 1993 to 2011. JAMA Intern Med. 2014;174(11):1837-1839. doi:10.1001/jamainternmed.2014.4344
    1. Kobayashi D, Shindo Y, Ito R, et al. . Validation of the prediction rules identifying drug-resistant pathogens in community-onset pneumonia. Infect Drug Resist. 2018;11:1703-1713. doi:10.2147/IDR.S165669
    1. Webb BJ, Dascomb K, Stenehjem E, Dean N. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model. Respir Med. 2015;109(1):1-10. doi:10.1016/j.rmed.2014.10.017
    1. McDonald LC. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis. 2006;42(suppl 2):S65-S71. doi:10.1086/499404

Source: PubMed

3
Subscribe